In her project she will utilize registry data as well as a questionnaire survey from newly-diagnosed type 2 diabetes patients. The main focus of her project is to determine risk factors for developing diabetic neuropathy and related diabetic foot disease in type 2 diabetes patients as well as clarifying the potential disease-modifying role of existing pharmacological therapies. As a component of her project, the validity of diagnosis codes for diabetic neuropathy and diabetic foot disease in the Danish National Registry of Patients will be assessed, and detailed algorithms to provide new ways of identifying diabetic neuropathy and diabetic foot disease in routine clinical care registries will be generated and validated.